GE HealthCare Technologies Inc. (GEHC)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | ||
|---|---|---|---|---|---|---|---|
| Receivables turnover | 187.32 | — | — | — | — | 3,214.00 | |
| DSO | days | 1.95 | — | — | — | — | 0.11 |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ 187.32
= 1.95
Based on the data provided for GE HealthCare Technologies Inc., the days of sales outstanding (DSO) ratio has been fluctuating over the reported periods.
As of September 30, 2023, the company had a very low DSO of 0.11 days, indicating that it collects its accounts receivable very quickly. However, for the subsequent periods (from December 31, 2023, to December 31, 2024), the DSO data is not available as it is reported as "— days," suggesting that the company may not have received or recorded any sales during these periods or there may be a data reporting issue.
The DSO ratio for December 31, 2024, shows a significant increase to 1.95 days, reflecting a slower collection of accounts receivable compared to the initial period. This increase in DSO could indicate potential issues with collecting payments from customers promptly, which may have implications for the company's cash flow and liquidity management.
Overall, the available data points to a varied performance in managing accounts receivable for GE HealthCare Technologies Inc., with a need for further analysis and monitoring to understand the reasons behind the fluctuations in the DSO ratio.
Peer comparison
Dec 31, 2024